Literature DB >> 29770

31P-NMR study on nucleotides and intracellular pH of hereditary spherocytes.

T Kagimoto, F Hayashi, M Yamasaki, Y Morino, K Akasaka, S Kishimoto.   

Abstract

As determined by 31p-NMR spectroscopy, intracellular pH of hereditary spherocytes was lower (pH 6.7-6.9) than that of normal red cells. The level of adenosine diphosphate in hereditary spherocytes was found to be persistently high. The metabolism of nucleotides and other phosphoryl compounds in human red blood cells have been studied in detail by 31p-MNR spectroscopy. However, to our knowledge, there seems to be no report describing the result of 31p-NMR spectroscopy on red blood cells from hereditary spherocytosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29770     DOI: 10.1007/BF01915368

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  4 in total

1.  PH-dependent changes of 2,3-bisphosphoglycerate in human red cells during transitional and steady states in vitro.

Authors:  I Rapoport; H Berger; R Elsner; S Rapoport
Journal:  Eur J Biochem       Date:  1977-03-01

2.  Phosphorus NMR studies on perfused heart.

Authors:  P B Garlick; G K Radda; P J Seeley
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

3.  Phosphorus-31 spectroscopic determinations of the phosphorus metabolite profiles of blood components: erythrocytes, reticulocytes, and platelets.

Authors:  R J Labotka; T Glonek; M A Hruby; G R Honig
Journal:  Biochem Med       Date:  1976-06

4.  Phosphate metabolism in intact human erythrocytes: determination by phosphorus-31 nuclear magnetic resonance spectroscopy.

Authors:  T O Henderson; A J Costello; A Omachi
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

  4 in total
  1 in total

1.  Detection of pyrimidine 5'-nucleotidase deficiency using 1H- or 31P-nuclear magnetic resonance.

Authors:  T Kagimoto; K Shirono; T Higaki; T Oda; H Matsuzaki; K Nagata; T Nakaji; Y Morino; K Takatsuki
Journal:  Experientia       Date:  1986-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.